EVEROLIMUS FACILITATES CALCINEURIN INHIBITOR WITHDRAWAL IN MAINTENANCE LIVER TRANSPLANT PATIENTS WITH RENAL IMPAIRMENT

被引：0
|
作者：
De Simone, Paolo [1 ]
Nevens, Frederik [2 ]
Metselaar, Harold. L. [3 ]
Sterneck, Martina [4 ]
Dumortier, Jerome [5 ]
Duvoux, Christophe [6 ]
Boudjema, Karim [4 ]
Le Treut, Yves-Patrice [7 ]
机构：
[1] Liver Transplant Unit, Pisa, Italy
[2] Univ Hosp Gasthuisberg, Louvain, Belgium
[3] Erasmus MC, Rotterdam, Netherlands
[4] Univ Hosp Hamburg Eppendorf, Hamburg, Germany
[5] Hop Edouard Herriot, Lyon, France
[6] Hop Henri Mondor, F-94010 Creteil, France
[7] Hop Conception, Marseille, France
来源：
LIVER TRANSPLANTATION | 2008年 / 14卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S225 / S225
页数：1
相关论文
共 50 条
  • [31] CALCINEURIN INHIBITOR WITHDRAWAL AND CONVERSION TO MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR (EVEROLIMUS) IN PEDIATRIC KIDNEY TRANSPLANT PATIENTS AT A TERTIARY HOSPITAL IN THAILAND
    Piyaphanee, Nuntawan
    Chaiyapak, Thanaporn
    Supavekin, Suroj
    Sumboonnanonda, Achra
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2017, 48 : 211 - 217
  • [32] EARLY WITHDRAWAL OF CALCINEURIN INHIBITORS AND EVEROLIMUS MONOTHERAPY IN DE NOVO LIVER TRANSPLANT RECIPIENTS
    Montalti, Roberto
    Rompianesi, Gianluca
    Masetti, Michele
    Di Benedetto, Fabrizio
    Cautero, Nicola
    De Ruvo, Nicola
    Guerrini, Gian Piero
    Ballarin, Roberto
    Smerieri, Nazareno
    Gerunda, Giorgio E.
    LIVER TRANSPLANTATION, 2009, 15 (07) : S96 - S97
  • [33] Everolimus for Calcineurin Inhibitor Minimization in Lung Transplant Recipients with Chronic Renal Insufficiency
    Schoeppler, K.
    Lyu, D.
    Kim, I.
    Grazia, T.
    Crossno, J.
    Christians, U.
    Zamora, M. R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S179 - S180
  • [34] Long-Term Outcomes of Calcineurin Inhibitor Withdrawal for Post-Liver Transplant Renal Dysfunction
    Mackay, A. J.
    Angus, P. W.
    Gow, P. J.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (10) : 3802 - 3806
  • [35] Pharmacokinetics of the immunosuppressant everolimus in maintenance renal transplant patients
    Budde, K
    Fritsche, L
    Waiser, J
    Glander, P
    Slowinski, T
    Neumayer, HH
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2005, 10 (04) : 169 - 174
  • [36] EFFICACY AND SAFETY OF AN EVEROLIMUS/ENTERICCOATED MYCOPHENOLATE SODIUM REGIMEN AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN DE NOVO RENAL TRANSPLANT PATIENTS: RESULTS OF THE ZEUS TRIAL
    Reinke, P.
    Arns, W.
    Becker, T.
    Eisenberger, U.
    Fischer, W.
    Kramer, S.
    Pietruck, F.
    Sommerer, C.
    Budde, K.
    TRANSPLANT INTERNATIONAL, 2009, 22 : 53 - 53
  • [37] Withdrawal of calcineurin inhibitors in liver transplant patients with drug-related renal insufficiency.
    Stieber, AC
    Smallwood, GA
    Davis, LP
    Heffron, TG
    HEPATOLOGY, 1999, 30 (04) : 184A - 184A
  • [38] Calcineurin-Inhibitor Minimization in Liver Transplant Patients with Calcineurin-Inhibitor-Related Renal Dysfunction: A Meta-Analysis
    Kong, Yuan
    Wang, Dongping
    Shang, Yushu
    Liang, Wenhua
    Ling, Xiaoting
    Guo, Zhiyong
    He, Xiaoshun
    PLOS ONE, 2011, 6 (09):
  • [39] Use of Everolimus for Calcineurin Inhibitor Minimization in Lung Transplant Recipients with Chronic Renal Insufficiency
    Schoeppler, K.
    Lyu, D.
    Christians, U.
    Kim, I.
    Grazia, T.
    Crossno, J.
    Zamora, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 414 - 414
  • [40] Mycophenolate mofetil in stable liver transplant patients with calcineurin inhibitor-induced renal impairment: Single-center experience
    Garcia, CE
    Ribeiro, HBG
    Garcia, RL
    Copstein, JLM
    Padilla, JM
    Santos, TE
    Amaral, DD
    Silva, AO
    D'Albucluerque, LAC
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (03) : 1131 - 1132
12345